Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 36, 2011, Pages 14813-14818

  Chen, Jianglei ^a   Li, Qianqian ^a   Wang, Jianjun ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E3; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEOHEPARAN SULFATE; VERY LOW DENSITY LIPOPROTEIN;

ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROSIS; BETA RHYTHM; BINDING AFFINITY; BIOGENESIS; DRUG BINDING; DRUG TRANSPORT; HUMAN; HYDROPHOBICITY; LIPID TRANSPORT; NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN TRANSPORT; SURFACE PROPERTY;

AMYLOID; APOLIPOPROTEIN E3; BIOLOGICAL TRANSPORT; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LDL-RECEPTOR RELATED PROTEIN 1; LIPID METABOLISM; LIPIDS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 80052604940     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1106420108     Document Type: Article

References (40)

1. Weisgraber KH (1994) Apolipoprotein E: Structure-function relationships. Adv Protein Chem 45:249-302.
2. Mahley RW, Weisgraber KH, Huang Y (2009) Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res 50(Suppl): S183-S188.
3. MahleyRW, Ji ZS (1999) Remnant lipoprotein metabolism: Key pathways involving cellsurface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 40:1-16. (Pubitemid 29022581)
4. Luc G, et al. (1994) Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb 14:1412-1419.
5. Mahley RW, Rall SC, Jr, eds. (2001) The Metabolic and Molecular Base of Inherited Disease ((McGraw-Hill), New York), 8 Ed, pp 2835-2862.
6. Burt TD, et al. (2008) Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc Natl Acad Sci USA 105:8718-8723. (Pubitemid 351987746)
7. Ma SW, Benzie IF, Yeung VT (2008) Type 2 diabetes mellitus and its renal complications in relation to apolipoprotein E gene polymorphism. Transl Res 152:134-142.
8. Wilson C, Wardell MR, Weisgraber KH, Mahley RW, Agard DA (1991) Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science 252:1817-1822. (Pubitemid 21917100)
9. Wardell MR, Rall SC, Jr, Schaefer EJ, Kane JP,Weisgraber KH (1991) Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity. J Lipid Res 32:521-528.
10. Morrow JA, et al. (2000) Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor. J Biol Chem 275:2576-2580. (Pubitemid 30082023)
11. Wilson C, et al. (1994) Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein. Structure 2:713-718.
12. Dong LM, et al. (1996) Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia. Nat Struct Biol 3:718-722.
13. Dong LM, et al. (1994) Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem 269:22358-22365.
14. Dong LM, Weisgraber KH (1996) Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem 271:19053-19057.
15. Zhang Y, et al. (2007) A monomeric, biologically active, full-length human apolipoprotein E. Biochemistry 46:10722-10732. (Pubitemid 47417264)
16. Zhang Y, Chen J, Wang J (2008) A complete backbone spectral assignment of lipid-free human apolipoprotein E (apoE). Biomol NMR Assigm 2:207-210.
17. ZhaoW, Zhang Y, Cui C, Li Q, Wang J (2008) An efficient on-column expressed protein ligation strategy: Application to segmental triple labeling of human apolipoprotein E3. Protein Sci 17:736-747. (Pubitemid 351480867)
18. Aggerbeck LP, Wetterau JR, Weisgraber KH, Wu CS, Lindgren FT (1988) Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. J Biol Chem 263:6249-6258.
19. Sivashanmugam A, Wang J (2009) A unified scheme for initiation and conformational adaptation of human apolipoprotein E N-terminal domain upon lipoprotein binding and for receptor binding activity. J Biol Chem 284:14657-14666.
20. Wetterau JR, Aggerbeck LP, Rall SC, Jr,Weisgraber KH (1988) Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J Biol Chem263:6240-6248.
21. Willard L, et al. (2003) VADAR: A web server for quantitative evaluation of protein structure quality. Nucleic Acids Res 31:3316-3319. (Pubitemid 37442148)
22. Morrow JA, et al. (2002) Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease. J Biol Chem 277:50380-50385. (Pubitemid 36042188)
23. Chroni A, et al. (2008) Biophysical analysis of progressive C-terminal truncations of human apolipoprotein E4: Insights into secondary structure and unfolding properties. Biochemistry 47:9071-9080.
24. Nguyen D, Dhanasekaran P, Phillips MC, Lund-Katz S (2009) Molecular mechanism of apolipoprotein E binding to lipoprotein particles. Biochemistry 48:3025-3032.
25. Li X, Kypreos K, Zanni EE, Zannis V (2003) Domains of apoE required for binding to apoE receptor 2 and to phospholipids: Implications for the functions of apoE in the brain. Biochemistry 42:10406-10417. (Pubitemid 37071440)
26. Narayanaswami V, et al. (2004) Helix orientation of the functional domains in apolipoprotein E in discoidal high density lipoprotein particles. J Biol Chem 279:14273-14279. (Pubitemid 38468967)
27. Narayanaswami V, Szeto SS, Ryan RO (2001) Lipid association-induced N- and C-terminal domain reorganization in human apolipoprotein E3. J Biol Chem 276:37853-37860.
28. Peters-Libeu CA, Newhouse Y, Hatters, DM, Weisgraber KH (2006) Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. J Biol Chem 281:1073-1079.
29. Narita M, et al. (2002) Cellular catabolism of lipid poor apolipoprotein E via cell surface LDL receptor-related protein. J Biochem 132:743-749. (Pubitemid 35408497)
30. Futamura M, et al. (2005) Two-step mechanism of binding of apolipoprotein E to heparin: Implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces. J Biol Chem 280:5414-5422. (Pubitemid 40280016)
31. Saito H, et al. (2003) Characterization of the heparin binding sites in human apolipoprotein E. J Biol Chem 278:14782-14787. (Pubitemid 36799803)
32. Libeu CP, et al. (2001) New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E. J Biol Chem 276:39138-39144.
33. Herz J,Marschang P (2003) Coaxing the LDL receptor family into the fold. Cell 112:289-292. (Pubitemid 36183650)
34. Innerarity TL, Friedlander EJ, Rall SC, Jr, Weisgraber KH, Mahley RW (1983) The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments. J Biol Chem 258:12341-12347. (Pubitemid 14230022)
35. Bu G, Schwartz AL (1998) RAP, a novel type of ER chaperone. Trends Cell Biol 8:272-276. (Pubitemid 128714336)
36. Ruiz J, et al. (2005) The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J Lipid Res 46:1721-1731. (Pubitemid 41099339)
37. Hobbs HH, Brown MS, Goldstein JL (1992) Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1:445-466.
38. Bu G (2009) Apolipoprotein E and its receptors in Alzheimer's disease: Pathways, pathogenesis and therapy. Nat Rev Neurosci 10:333-344.
39. Chen J,Wang J (2011) A segmental labeling strategy for unambiguous determination of domain-domain interactions of large multi-domain proteins. J BiomolNMR 50:403-410.
40. Guntert P (2004) Automated NMR structure calculation with CYANA. Method Mol Biol 278:353-378.